US Stock MarketDetailed Quotes

CKPT Checkpoint Therapeutics

Watchlist
  • 3.670
  • -0.130-3.42%
Close Dec 13 16:00 ET
  • 4.270
  • +0.600+16.35%
Post 19:59 ET
179.22MMarket Cap-2.01P/E (TTM)

Checkpoint Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
32.26%41K
0
-46.35%103K
-91.89%6K
-35.42%31K
72.22%31K
-32.69%35K
-28.36%192K
362.50%74K
Operating revenue
--0
32.26%41K
--0
-46.35%103K
-91.89%6K
-35.42%31K
72.22%31K
-32.69%35K
-28.36%192K
362.50%74K
Cost of revenue
Gross profit
Operating expense
25.76%9.72M
-58.62%6.71M
-39.57%10.95M
-10.72%52.25M
-39.14%10.18M
-27.82%7.73M
14.41%16.23M
7.12%18.12M
2.69%58.53M
-43.87%16.72M
Selling and administrative expenses
50.18%3.36M
-2.06%2.23M
6.94%2.45M
-0.17%8.69M
-24.42%1.88M
21.13%2.24M
7.14%2.28M
2.18%2.29M
1.90%8.7M
16.64%2.48M
-General and administrative expense
50.18%3.36M
-2.06%2.23M
6.94%2.45M
-0.17%8.69M
-24.42%1.88M
21.13%2.24M
7.14%2.28M
2.18%2.29M
1.90%8.7M
16.64%2.48M
Research and development costs
15.83%6.37M
-67.87%4.48M
-46.31%8.5M
-12.56%43.57M
-41.70%8.3M
-38.01%5.5M
15.70%13.95M
7.88%15.83M
2.83%49.83M
-48.53%14.24M
Operating profit
-26.27%-9.72M
58.80%-6.67M
39.46%-10.95M
10.60%-52.15M
38.90%-10.17M
27.79%-7.7M
-14.34%-16.2M
-7.25%-18.08M
-2.84%-58.33M
44.09%-16.64M
Net non-operating interest income expense
-71.43%2K
-90.32%3K
-90.70%4K
-47.50%84K
-95.89%3K
-86.54%7K
40.91%31K
230.77%43K
201.89%160K
421.43%73K
Non-operating interest income
-71.43%2K
-90.32%3K
-90.70%4K
-47.50%84K
-95.89%3K
-86.54%7K
40.91%31K
230.77%43K
201.89%160K
421.43%73K
Other net income (expense)
-100.15%-3K
-100.01%-1K
104.88%217K
-8.96M
1.97M
-357K
7.57M
-4.45M
Gain on sale of security
-100.15%-3K
----
-100.01%-1K
104.88%217K
---8.96M
--1.97M
---357K
--7.57M
---4.45M
----
Income before tax
-69.90%-9.73M
59.63%-6.67M
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
Income tax
Net income
-69.90%-9.73M
59.63%-6.67M
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
Net income continuous Operations
-69.90%-9.73M
59.63%-6.67M
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
Minority interest income
Net income attributable to the parent company
-69.90%-9.73M
59.63%-6.67M
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-69.90%-9.73M
59.63%-6.67M
-4.50%-10.95M
17.21%-51.85M
9.01%-19.13M
46.06%-5.72M
-16.82%-16.52M
37.83%-10.47M
-10.51%-62.62M
29.35%-21.02M
Basic earnings per share
20.69%-0.23
82.86%-0.18
62.92%-0.33
55.29%-3.17
52.38%-1.1
75.83%-0.29
35.19%-1.05
55.05%-0.89
4.83%-7.09
40.00%-2.31
Diluted earnings per share
20.69%-0.23
82.86%-0.18
62.92%-0.33
55.29%-3.17
52.38%-1.1
75.83%-0.29
35.19%-1.05
55.05%-0.89
4.83%-7.09
40.00%-2.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 032.26%41K0-46.35%103K-91.89%6K-35.42%31K72.22%31K-32.69%35K-28.36%192K362.50%74K
Operating revenue --032.26%41K--0-46.35%103K-91.89%6K-35.42%31K72.22%31K-32.69%35K-28.36%192K362.50%74K
Cost of revenue
Gross profit
Operating expense 25.76%9.72M-58.62%6.71M-39.57%10.95M-10.72%52.25M-39.14%10.18M-27.82%7.73M14.41%16.23M7.12%18.12M2.69%58.53M-43.87%16.72M
Selling and administrative expenses 50.18%3.36M-2.06%2.23M6.94%2.45M-0.17%8.69M-24.42%1.88M21.13%2.24M7.14%2.28M2.18%2.29M1.90%8.7M16.64%2.48M
-General and administrative expense 50.18%3.36M-2.06%2.23M6.94%2.45M-0.17%8.69M-24.42%1.88M21.13%2.24M7.14%2.28M2.18%2.29M1.90%8.7M16.64%2.48M
Research and development costs 15.83%6.37M-67.87%4.48M-46.31%8.5M-12.56%43.57M-41.70%8.3M-38.01%5.5M15.70%13.95M7.88%15.83M2.83%49.83M-48.53%14.24M
Operating profit -26.27%-9.72M58.80%-6.67M39.46%-10.95M10.60%-52.15M38.90%-10.17M27.79%-7.7M-14.34%-16.2M-7.25%-18.08M-2.84%-58.33M44.09%-16.64M
Net non-operating interest income expense -71.43%2K-90.32%3K-90.70%4K-47.50%84K-95.89%3K-86.54%7K40.91%31K230.77%43K201.89%160K421.43%73K
Non-operating interest income -71.43%2K-90.32%3K-90.70%4K-47.50%84K-95.89%3K-86.54%7K40.91%31K230.77%43K201.89%160K421.43%73K
Other net income (expense) -100.15%-3K-100.01%-1K104.88%217K-8.96M1.97M-357K7.57M-4.45M
Gain on sale of security -100.15%-3K-----100.01%-1K104.88%217K---8.96M--1.97M---357K--7.57M---4.45M----
Income before tax -69.90%-9.73M59.63%-6.67M-4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M
Income tax
Net income -69.90%-9.73M59.63%-6.67M-4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M
Net income continuous Operations -69.90%-9.73M59.63%-6.67M-4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M
Minority interest income
Net income attributable to the parent company -69.90%-9.73M59.63%-6.67M-4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -69.90%-9.73M59.63%-6.67M-4.50%-10.95M17.21%-51.85M9.01%-19.13M46.06%-5.72M-16.82%-16.52M37.83%-10.47M-10.51%-62.62M29.35%-21.02M
Basic earnings per share 20.69%-0.2382.86%-0.1862.92%-0.3355.29%-3.1752.38%-1.175.83%-0.2935.19%-1.0555.05%-0.894.83%-7.0940.00%-2.31
Diluted earnings per share 20.69%-0.2382.86%-0.1862.92%-0.3355.29%-3.1752.38%-1.175.83%-0.2935.19%-1.0555.05%-0.894.83%-7.0940.00%-2.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data